Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Timser SAPI de CV
GI Innovation, Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Centre Oscar Lambret
Seagen Inc.
University of Kansas Medical Center
N.N. Alexandrov National Cancer Centre
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Seagen Inc.
M.D. Anderson Cancer Center
Washington University School of Medicine
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Ataturk University
Hoffmann-La Roche
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Pfizer
Fudan University
M.D. Anderson Cancer Center
Basic Health International, Inc.
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
Kivu Bioscience Inc.
University Hospital Heidelberg
Alterome Therapeutics, Inc.
M.D. Anderson Cancer Center
MediLink Therapeutics (Suzhou) Co., Ltd.
University Health Network, Toronto
Duke University
Duke University
Medtronic - MITG
Washington University School of Medicine
University Health Network, Toronto
University College Cork
Bayer
University of Cincinnati
National Taiwan University Hospital
Timser SAPI de CV
Convalife (Shanghai) Co., Ltd.